Characterization of an anaphylactoid reaction to omalizumab

Complications of intravenous immune globulin treatment in neurologic disease

Thomas H. Brannagan, Keith J. Nagle, Dale J. Lange et al. · Neurology · 1996 · 213 citations

Medicine, Neurology, Comparative Effectiveness Research +8

Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma

William E. Berger, Niroo Gupta, Margaret McAlary et al. · Annals of Allergy Asthma & Immunology · 2003 · 183 citations

Life Sciences, Immunology, Pediatrics +16

Omalizumab is effective in the long-term control of severe allergic asthma

Bobby Q. Lanier, Jonathan Corren, William R. Lumry et al. · Annals of Allergy Asthma & Immunology · 2003 · 183 citations

Life Sciences, Immunology, Pharmacology +13

Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.

Rephael Zeltser, Laura Valle, Carol Tanck et al. · PubMed · 2001 · 170 citations

Medicine, Dermatology, Immunology +17

Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.

Athimalaipet V Ramanan, Rayfel Schneider · PubMed · 2003 · 163 citations

Life Sciences, Immunology, Pediatrics +12